Table 5.
Association between sleep medication at baseline and incident depressive symptoms over 4-year follow-up
Model 1 |
Model 2 |
Model 3 |
|||||||
---|---|---|---|---|---|---|---|---|---|
Variable | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P |
Prescribed sleep medication | |||||||||
Yes vs No | 1.70 | 1.33-2.19 | < 0.0001 | 1.62 | 1.26-2.09 | 0.0002 | 1.71 | 1.33-2.20 | < 0.0001 |
Homeopathic and non-prescription treatments | |||||||||
Yes vs No | 1.48 | 0.75-2.91 | 0.25 | 1.38 | 0.70-2.72 | 0.35 | 1.52 | 0.77-3.00 | 0.23 |
Model 1 was adjusted for center, CES-D baseline, gender, age, education, living alone, coffee consumption, alcohol consumption, smoking, chronic disease, past major depression, and disability. Model 2 was adjusted for all the covariates in model 1 plus insomnia symptoms. Model 3 was adjusted for all the covariates in model 1 plus EDS.